康众医疗
(688607)
| 流通市值：15.74亿 | | | 总市值：15.74亿 |
| 流通股本：8812.90万 | | | 总股本：8812.90万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 195,501,808.26 | 128,884,465.05 | 52,969,765.8 | 273,743,126.41 |
| 营业收入 | 195,501,808.26 | 128,884,465.05 | 52,969,765.8 | 273,743,126.41 |
| 二、营业总成本 | 187,959,296.34 | 124,636,325.65 | 53,280,817.38 | 263,882,523.32 |
| 营业成本 | 111,618,458.75 | 76,063,051.04 | 30,984,759.69 | 165,210,552.97 |
| 税金及附加 | 1,541,365.32 | 1,314,216.96 | 440,069.25 | 1,165,985.61 |
| 销售费用 | 25,087,036.19 | 15,692,268.64 | 7,313,257.47 | 27,349,839.66 |
| 管理费用 | 18,711,493.31 | 11,823,463.24 | 4,914,572.71 | 29,359,890.96 |
| 研发费用 | 30,522,635.51 | 20,970,442.56 | 10,369,812.18 | 44,598,095.92 |
| 财务费用 | 478,307.26 | -1,227,116.79 | -741,653.92 | -3,801,841.8 |
| 其中:利息费用 | 754,092.88 | 302,182.83 | 202,962.67 | 506,430.84 |
| 其中:利息收入 | 438,095.71 | 655,557.69 | 61,519.5 | 1,493,932.71 |
| 加:公允价值变动收益 | -1,425,050.19 | -711,236.49 | -216,016.31 | 1,411,334.77 |
| 加:投资收益 | 7,899,779.41 | 4,829,724.7 | 2,482,896.33 | 8,730,140.55 |
| 资产处置收益 | - | - | - | 185,600.98 |
| 资产减值损失(新) | -1,178,675.91 | -479,459.04 | -296,541.53 | -5,731,719.1 |
| 信用减值损失(新) | -918,152.39 | -1,227,486.96 | -292,188.63 | -2,345,613.55 |
| 其他收益 | 2,185,374.03 | 1,401,672.16 | 671,246.78 | 1,723,457.49 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 14,105,786.87 | 8,061,353.77 | 2,038,345.06 | 13,833,804.23 |
| 加:营业外收入 | 314,144.75 | 85,001.76 | 5,538.09 | 1,474,564.26 |
| 减:营业外支出 | 36,812.98 | 34,484.47 | 4,645.62 | 6,546.15 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 14,383,118.64 | 8,111,871.06 | 2,039,237.53 | 15,301,822.34 |
| 减:所得税费用 | 1,791,208.95 | 803,753.27 | 848,481.08 | -105,772.08 |
| 六、净利润 | 12,591,909.69 | 7,308,117.79 | 1,190,756.45 | 15,407,594.42 |
| 持续经营净利润 | 12,591,909.69 | 7,308,117.79 | 1,190,756.45 | 15,407,594.42 |
| 归属于母公司股东的净利润 | 12,586,307.98 | 7,317,939.67 | 1,168,820.49 | 15,412,206.47 |
| 少数股东损益 | 5,601.71 | -9,821.88 | 21,935.96 | -4,612.05 |
| (一)基本每股收益 | 0.14 | 0.08 | 0.01 | 0.17 |
| (二)稀释每股收益 | 0.14 | 0.08 | 0.01 | 0.17 |
| 八、其他综合收益 | -3,301,607.96 | -368,412.3 | -440,983.48 | -1,641,850.68 |
| 归属于母公司股东的其他综合收益 | -3,300,787.87 | -368,221.19 | -440,983.48 | -1,635,559.23 |
| 九、综合收益总额 | 9,291,941.91 | 6,939,705.49 | 749,772.97 | 13,765,743.74 |
| 归属于母公司股东的综合收益总额 | 9,285,520.11 | 6,949,718.48 | 727,837.01 | 13,776,647.24 |
| 归属于少数股东的综合收益总额 | 6,421.8 | -10,012.99 | 21,935.96 | -10,903.5 |
| 公告日期 | 2024-10-26 | 2024-08-24 | 2024-04-27 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |